SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001140361-23-031407
Filing Date
2023-06-26
Accepted
2023-06-26 16:06:30
Documents
17

Document Format Files

Seq Description Document Type Size
1 PRER14A ny20006478x6_prer14a.htm PRER14A 10540312
2 ny20006478x4_graphic09.jpg GRAPHIC 6973
3 ny20006478x6_bargraph01.jpg GRAPHIC 169174
4 ny20006478x6_bargraph02.jpg GRAPHIC 163569
5 ny20006478x6_graphic01.jpg GRAPHIC 279182
6 ny20006478x6_graphic01x1.jpg GRAPHIC 308469
7 ny20006478x6_graphic02.jpg GRAPHIC 166260
8 ny20006478x6_graphic03.jpg GRAPHIC 35752
9 ny20006478x6_graphic04.jpg GRAPHIC 329745
10 ny20006478x6_graphic05.jpg GRAPHIC 203401
11 ny20006478x6_graphic06.jpg GRAPHIC 313708
12 ny20006478x6_graphic07.jpg GRAPHIC 91420
13 ny20006478x6_graphic08ax1.jpg GRAPHIC 32560
14 ny20006478x6_graphic08bx1.jpg GRAPHIC 139731
15 ny20006478x6_graphic08cx1.jpg GRAPHIC 166445
16 ny20006478x6_pc01.jpg GRAPHIC 833753
17 ny20006478x6_pc02.jpg GRAPHIC 763081
  Complete submission text file 0001140361-23-031407.txt   16051621
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 000-51173 | Film No.: 231042402
SIC: 2834 Pharmaceutical Preparations